Maravai Lifesciences Holdings (MRVI) Debt Ratio (2020 - 2026)

Maravai Lifesciences Holdings' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.35 for Q1 2026.

• On a quarterly basis, Debt Ratio rose 12.44% year-over-year to 0.35 in Q1 2026; TTM through Mar 2026 was 0.35, a 12.44% increase from a year earlier, with the FY2025 full-year figure at 0.38, up 26.67% from the prior year.
• Debt Ratio declined to 0.35 in Q1 2026 per MRVI's latest filing, from 0.38 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.41 in Q3 2024 and bottomed at 0.23 in Q4 2022.
• The 5-year median for Debt Ratio is 0.33 (2025), against an average of 0.32.
• Across the five-year window, Debt Ratio sank 32.4% in 2023 and soared 76.3% in 2024, its largest moves.
• Year by year, Debt Ratio stood at 0.23 in 2022, then soared by 54.06% to 0.36 in 2023, then retreated by 16.05% to 0.3 in 2024, then climbed by 26.67% to 0.38 in 2025, then dropped by 8.74% to 0.35 in 2026.
• Per Business Quant, the three latest MRVI Debt Ratio figures stand at 0.35 (Q1 2026), 0.38 (Q4 2025), and 0.34 (Q3 2025).